BioCentury | Jul 4, 2011
Company News

GlycoRegImmune, RxMD deal

...NK) T cell targeted technologies for yet to be determined inflammatory, autoimmune and neurodegenerative diseases. RxMD...
...Molecular Studies last month and in July 2009, respectively. GlycoRegImmune Inc. , La Jolla, Calif. RxMD Inc....
Items per page:
1 - 1 of 1
BioCentury | Jul 4, 2011
Company News

GlycoRegImmune, RxMD deal

...NK) T cell targeted technologies for yet to be determined inflammatory, autoimmune and neurodegenerative diseases. RxMD...
...Molecular Studies last month and in July 2009, respectively. GlycoRegImmune Inc. , La Jolla, Calif. RxMD Inc....
Items per page:
1 - 1 of 1